Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia.
about
Newer positron emission tomography radiopharmaceuticals for radiotherapy planning: an overviewPositron emission tomography to assess hypoxia and perfusion in lung cancerHeptamethine cyanine based (64)Cu-PET probe PC-1001 for cancer imaging: synthesis and in vivo evaluation.Molecular imaging of hypoxia.Copper complexation screen reveals compounds with potent antibiotic properties against methicillin-resistant Staphylococcus aureus.PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidenceCoordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of diseaseDetection of hypoxia in microscopic tumors using 131I-labeled iodo-azomycin galactopyranoside (131I-IAZGP) digital autoradiography.Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PETPerformance of a ⁶²Zn/⁶²Cu microgenerator in kit-based synthesis and delivery of [⁶²Cu]Cu-ETS for PET perfusion imaging(18)F-misonidazole PET imaging of hypoxia in micrometastases and macroscopic xenografts of human non-small cell lung cancer: a correlation with autoradiography and histological findings.Evaluation of hypoxia in a feline model of head and neck cancer using ⁶⁴Cu-ATSM positron emission tomography/computed tomography.Evaluation of hypoxia with copper-labeled diacetyl-bis(N-methylthiosemicarbazone).In vitro and in vivo evaluation of bifunctional bisthiosemicarbazone 64Cu-complexes for the positron emission tomography imaging of hypoxia.An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervixNitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) - Potential combination agents for the PET imaging of hypoxia.Assessing tumor hypoxia by positron emission tomography with Cu-ATSMMouse model of necrotic tuberculosis granulomas develops hypoxic lesionsMycobacteria, metals, and the macrophageLongitudinal tumor hypoxia imaging with [(18)F]FAZA-PET provides early prediction of nanoliposomal irinotecan (nal-IRI) treatment activity.Iron-targeting antitumor activity of gallium compounds and novel insights into triapine(®)-metal complexes.Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals.Copper-64 Radiopharmaceuticals for Oncologic ImagingAutoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer.A practical guide to the construction of radiometallated bioconjugates for positron emission tomography.A novel technology for the imaging of acidic prostate tumors by positron emission tomography.Pharmacotherapeutic targets in Alzheimer's diseaseMolecular imaging of hypoxia with radiolabelled agentsExamining the relationship between Cu-ATSM hypoxia selectivity and fatty acid synthase expression in human prostate cancer cell lines.CuII(atsm) improves the neurological phenotype and survival of SOD1G93A mice and selectively increases enzymatically active SOD1 in the spinal cordPositron Emission Tomography Imaging of Hypoxia.Multimodal radio- (PET/SPECT) and fluorescence imaging agents based on metallo-radioisotopes: current applications and prospects for development of new agents.Techniques of assessing hypoxia at the bench and bedside.Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals.The rise of metal radionuclides in medical imaging: copper-64, zirconium-89 and yttrium-86.Copper complexes as therapeutic agents.Molecular Imaging of Hypoxia: Strategies for Probe Design and Application.Tumour targeting with radiometals for diagnosis and therapy.Radiocopper for the imaging of copper metabolism.
P2860
Q26767172-F6C5B02E-0630-43AC-BB5B-F42B503A62F7Q27026940-6CB34B13-927A-4F7E-A384-403B7A3FC4F7Q30414100-FA906F77-1170-47CF-A884-6631EDDDC418Q30460766-2C03BFFF-CA6F-483B-9ADE-0ADE329591D1Q33798397-293B6C31-A51F-4F9D-B21C-3472A8DBF55EQ33818999-644AF36D-40B5-4A79-96C2-0E3F18FEECE5Q33870879-4D621787-92AC-4F09-9D74-0AB574701EB7Q33936624-00027CAE-F5F9-4E19-9B33-47C2D082FC62Q34119201-86E64B95-F65D-4F8B-9F1C-D8EB8621AC84Q34235986-DD3A6C01-C6E0-4164-9A5F-0D3240A82153Q34407288-CFA51BA9-A560-428E-812C-6CAA33CBA35CQ34633783-57A7F500-E88B-4EEC-BE11-F6CC4D749331Q34696310-3DC6B420-356A-42BD-8C57-43A708B49131Q35116540-D26EA868-189B-43A4-B79B-CFE0FF67384CQ35504360-5FD6FE90-2175-4D4C-8941-CECDF8762D56Q35545519-D49E1D14-1D29-44A7-AFB9-EA7EF6E0B33FQ35545523-EBE0451D-2D76-4AC5-BBC0-36AC90F63661Q35565683-B62B5C1F-9398-464F-B6F2-A8BAE857C7B7Q35694718-583657DD-4105-44FE-BA8C-F9D85AF352F1Q35907046-697A002E-5D2F-43CD-8A5B-092544F7F8C4Q36177290-4F3A1C2C-F60B-4F0A-8589-6145EFBD4B1CQ36568904-315D9A4A-E6EB-426F-8712-91D321E53C1BQ37026964-5B622572-E2F0-4D4D-834F-DDF01B236FC9Q37126530-B79BFDD7-030B-4F7F-A800-E2A7BF1DD2C6Q37140996-E31D57E8-1294-465D-8836-8987719D931FQ37172093-7DC33C93-F448-425C-9E1D-26D71565C6F6Q37213034-136D5EB4-743C-4915-871A-23CA1F0C62B9Q37295067-8DB401D2-B30F-4BB7-996A-36C385CDC051Q37378239-87D0DE75-9F48-49B6-A29D-BC6F973A607EQ37414432-843A8191-5B8B-4636-93C4-97F7BE62A35FQ37638093-D9D120CE-8B92-4938-9FA3-C4069E6C015FQ37666742-03613942-8A71-4257-A1D0-236CF77ED448Q37827710-99B657DF-3939-4D01-B154-2F3012896EE7Q37843729-8FF1E6AD-20C9-4B31-BA5D-22E820B147E2Q37853427-F921F631-A05B-4467-99EE-DBFBED5068E1Q37869905-31F8169A-E499-4037-AC92-9FD6EAAA4E7EQ37970312-EC99A0EA-7E86-46C8-AC4A-B083394C66D0Q37986039-9ACB45D5-E968-4132-9C5B-7A162E4F6538Q38100112-CAC47835-57C7-4F9F-8F7C-FB4A106D3263Q38196380-D1233542-44B1-48FE-A8F7-B496218FD8EE
P2860
Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia.
@en
type
label
Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia.
@en
prefLabel
Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia.
@en
P356
P1433
P1476
Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia.
@en
P2093
Amy L Vāvere
Jason S Lewis
P2860
P304
P356
10.1039/B705989B
P407
P577
2007-09-25T00:00:00Z